- Home
- VCEL vs EVT Comparison
VCEL vs EVT Comparison
Compare VCEL & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- EVT
- Stock Information
- Founded
- VCEL 1989
- EVT 2003
- Country
- VCEL United States
- EVT United States
- Employees
- VCEL N/A
- EVT N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- EVT Finance Companies
- Sector
- VCEL Health Care
- EVT Finance
- Exchange
- VCEL Nasdaq
- EVT Nasdaq
- Market Cap
- VCEL 2.1B
- EVT 1.7B
- IPO Year
- VCEL 1997
- EVT N/A
- Fundamental
- Price
- VCEL $34.05
- EVT $24.34
- Analyst Decision
- VCEL Strong Buy
- EVT
- Analyst Count
- VCEL 6
- EVT 0
- Target Price
- VCEL $61.50
- EVT N/A
- AVG Volume (30 Days)
- VCEL 565.9K
- EVT 115.5K
- Earning Date
- VCEL 07-31-2025
- EVT 01-01-0001
- Dividend Yield
- VCEL N/A
- EVT 8.32%
- EPS Growth
- VCEL 2045.40
- EVT N/A
- EPS
- VCEL 0.13
- EVT 6.63
- Revenue
- VCEL $249,119,000.00
- EVT $69,404,302.00
- Revenue This Year
- VCEL $18.35
- EVT N/A
- Revenue Next Year
- VCEL $22.47
- EVT N/A
- P/E Ratio
- VCEL $256.98
- EVT $3.55
- Revenue Growth
- VCEL 16.13
- EVT N/A
- 52 Week Low
- VCEL $33.09
- EVT $19.20
- 52 Week High
- VCEL $63.00
- EVT $25.83
- Technical
- Relative Strength Index (RSI)
- VCEL 40.14
- EVT 57.26
- Support Level
- VCEL $33.34
- EVT $24.07
- Resistance Level
- VCEL $36.81
- EVT $24.57
- Average True Range (ATR)
- VCEL 1.36
- EVT 0.20
- MACD
- VCEL -0.13
- EVT 0.01
- Stochastic Oscillator
- VCEL 20.14
- EVT 64.06
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.